HCA Healthcare Inc. stock outperforms competitors on strong trading day
HCA Healthcare Inc. (HCA) stock rose 5.64% to $429.19 on Friday, outperforming the broader market which also saw gains in the S&P 500 Index and the Dow Jones Industrial Average. This increase ended a two-day losing streak for the company's shares. The strong trading day for HCA occurred amidst a generally favorable session for the stock market.
HCA Healthcare Jumps 6.0% After JP Morgan Maintains Neutral
HCA Healthcare shares surged 6.0% to $430.79 on Friday, despite JP Morgan cutting its price target from $490 to $425 and maintaining a Neutral rating. The unexpected rally suggests investors may be looking beyond the analyst's more conservative outlook, possibly anticipating stronger operational performance or improved industry fundamentals. This divergence highlights the complexity of market sentiment around HCA, a major hospital operator, as trading volume reached 750,059 shares.
HCA Healthcare Inc Stock (HCA) Moved Up by 5.35% on Aug 21: Drivers Behind the Movement
HCA Healthcare Inc (HCA) stock surged by 5.35% on August 21, driven by robust quarterly operating results with strong patient admissions, institutional accumulation, and strategic outpatient expansion. The company reported annual revenue of $75.60 billion and a net profit of $6.78 billion. Technical indicators show a buy signal with a neutral RSI, while fundamental analysis highlights its strong industry ranking despite low media coverage and some company-specific risks like potential price target cuts.
Paralel Advisors LLC Purchases Shares of 4,883 HCA Healthcare, Inc. $HCA
Paralel Advisors LLC has acquired 4,883 shares of HCA Healthcare, Inc., valued at approximately $1.9 million, bringing the total institutional ownership to 62.73%. Despite some analyst price target reductions, the stock holds a "Moderate Buy" consensus rating with a target of $462.64, significantly above its recent trading price. HCA Healthcare also reported strong quarterly earnings, beating expectations with $7.59 adjusted EPS and $20.23 billion in revenue, and declared a quarterly dividend of $0.78 per share.
5,422 Shares in HCA Healthcare, Inc. $HCA Bought by Silvant Capital Management LLC
Silvant Capital Management LLC acquired 5,422 shares of HCA Healthcare, Inc. valued at approximately $2.1 million during the second quarter. Institutional investors hold a significant 62.73% stake in the company. Despite recent price target reductions, HCA Healthcare maintains a consensus "Moderate Buy" rating from analysts, driven by strong quarterly earnings and revenue growth.
NewEdge Wealth LLC Invests $2.44 Million in HCA Healthcare, Inc. $HCA
NewEdge Wealth LLC has invested approximately $2.44 million in HCA Healthcare, Inc. by acquiring 6,258 shares during the second quarter. HCA Healthcare reported strong quarterly earnings of $7.59 per share and revenue of $20.23 billion, surpassing analyst estimates, and declared a quarterly dividend of $0.78 per share. Despite a recent stock dip, analysts generally maintain a "Moderate Buy" rating with an average price target of $462.64, indicating potential upside from its current price of $406.33.
Vise Technologies Inc. Takes $5.98 Million Position in HCA Healthcare, Inc. $HCA
Vise Technologies Inc. has acquired a new stake of 15,333 shares in HCA Healthcare, Inc. worth approximately $5.98 million during the second quarter. Several other institutional investors also adjusted their holdings in HCA Healthcare, which reported strong quarterly earnings of $7.59 EPS, surpassing analyst estimates. HCA Healthcare also declared a quarterly dividend of $0.78 per share, and analysts maintain a "Moderate Buy" consensus rating with a target price of $462.64.
Wealthfront Advisers LLC Makes New Investment in ResMed Inc. $RMD
Wealthfront Advisers LLC has acquired 8,748 shares of ResMed Inc. (NYSE:RMD) in the second quarter, a new investment valued at approximately $1.7 million. This move is part of broader institutional investor activity, with several other hedge funds also establishing new positions in ResMed. The article also details recent analyst ratings, financial performance, a dividend increase, and insider stock sales for ResMed.
Fairtree Asset Management Pty Ltd Makes New $1.15 Million Investment in HCA Healthcare, Inc. $HCA
Fairtree Asset Management Pty Ltd has initiated a new position in HCA Healthcare, Inc. (NYSE:HCA) by purchasing 2,939 shares valued at approximately $1.15 million during the second quarter. This move comes as several other institutional investors have also adjusted their stakes in HCA Healthcare, and analysts have provided varied price targets and ratings for the stock. HCA Healthcare recently reported strong quarterly earnings, surpassing analyst estimates, and announced a quarterly dividend.
Bank of New York Mellon Corp Takes $818.03 Million Position in ResMed Inc. $RMD
Bank of New York Mellon Corp has acquired a significant position in ResMed Inc. (NYSE:RMD), purchasing over 4.19 million shares valued at approximately $818.03 million in the second quarter. This move positions Bank of New York Mellon Corp as a major institutional investor, owning about 2.89% of ResMed. The article also details other hedge fund activities, analyst ratings, insider transactions, and ResMed's recent financial performance, including its increased quarterly dividend.
HCA Healthcare, Inc. to Present at September Conferences
HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at two healthcare conferences in September 2026: the Wells Fargo Healthcare Conference on September 9 and the Jefferies Healthcare Conference on September 15. Live audio webcasts and presentation materials will be available on the Investor Relations section of the Company’s website. HCA Healthcare is a leading healthcare services provider with 190 hospitals and approximately 2,600 ambulatory sites across 19 states and the United Kingdom.
ResMed (NYSE:RMD) Upgraded to Hold at Rothschild & Co Redburn
Rothschild & Co Redburn upgraded ResMed (NYSE:RMD) to a "Hold" rating, aligning with the broader analyst consensus. Despite recent insider stock sales, ResMed exceeded Q2 earnings expectations with $2.95 EPS and $1.46 billion in revenue. The stock has a current market capitalization of $33.30 billion and a P/E ratio of 22.13.
18,176 Shares in HCA Healthcare, Inc. $HCA Purchased by Wealthfront Advisers LLC
Wealthfront Advisers LLC recently acquired 18,176 shares of HCA Healthcare, Inc. (NYSE:HCA) valued at approximately $7.09 million during the second quarter. Other institutional investors have also adjusted their holdings in HCA, which currently has a "Moderate Buy" rating from analysts with an average price target of $465.59. The company recently reported strong quarterly earnings, beating consensus estimates, and declared a quarterly dividend of $0.78 per share.
Csenge Advisory Group Invests $1.03 Million in HCA Healthcare, Inc. $HCA
Csenge Advisory Group recently invested $1.03 million in HCA Healthcare, acquiring 2,638 shares. This comes as institutional investors collectively own 62.73% of the company, with major funds like BlackRock Inc. and State Street Corp increasing their stakes. Despite some recent target price reductions, analysts maintain a "Moderate Buy" consensus rating for HCA Healthcare, which also reported strong quarterly earnings and declared a quarterly dividend.
HCA Healthcare Inc. stock outperforms competitors despite losses on the day
HCA Healthcare Inc. (HCA) saw its stock price slide by 1.14% to $407.05 on Wednesday, despite a generally positive trading session for the broader stock market, with the S&P 500 and Dow Jones Industrial Average both posting gains. This decline broke a two-day winning streak for HCA Healthcare.
Meeder Advisory Services Inc. Acquires Shares of 5,936 HCA Healthcare, Inc. $HCA
Meeder Advisory Services Inc. has purchased a new stake of 5,936 shares in HCA Healthcare, Inc. (NYSE:HCA) valued at approximately $2.314 million during the second quarter. Other institutional investors have also adjusted their positions in HCA Healthcare. The company recently announced a quarterly dividend of $0.78 per share, with an ex-dividend date of September 16th.
Mitsubishi UFJ Asset Management Co. Ltd. Invests $147.94 Million in HCA Healthcare, Inc. $HCA
Mitsubishi UFJ Asset Management Co. Ltd. recently acquired a new stake in HCA Healthcare, purchasing 379,450 shares valued at approximately $147.94 million in the second quarter, representing 0.18% of the company's stock. Other institutional investors have also adjusted their holdings in HCA Healthcare, which currently has a "Moderate Buy" rating from analysts with an average target price of $465.59. The company also announced a quarterly dividend of $0.78 per share, payable on September 30th.
2,710 Shares in HCA Healthcare, Inc. $HCA Acquired by Perigon Wealth Management LLC
Perigon Wealth Management LLC acquired 2,710 shares of HCA Healthcare, Inc. (NYSE:HCA) valued at approximately $1.06 million during the second quarter. The article details other institutional investments, analyst ratings, and the company's financial performance, including exceeding quarterly expectations and declaring a $0.78 per share dividend. HCA Healthcare maintains a "Moderate Buy" consensus rating among analysts.
Deutsche Bank AG Acquires Shares of 451,372 HCA Healthcare, Inc. $HCA
Deutsche Bank AG has acquired a new position of 451,372 shares in HCA Healthcare, Inc., valued at approximately $175.99 million during the second quarter. Other institutional investors have also significantly increased or initiated stakes in HCA Healthcare. The company recently reported strong quarterly earnings, beating analyst estimates, and announced a quarterly dividend of $0.78 per share.
Compass Wealth Management LLC Takes Position in HCA Healthcare, Inc. $HCA
Compass Wealth Management LLC has acquired 11,026 shares of HCA Healthcare, Inc., valued at approximately $4.3 million, marking a new position in the company during the second quarter. Institutional investors collectively hold 62.73% of HCA Healthcare. Analysts currently assign a "Moderate Buy" consensus rating with a target price of $465.59, and HCA Healthcare recently surpassed quarterly earnings and revenue expectations while also declaring a quarterly dividend.
Foster & Motley Inc. Takes $11.03 Million Position in HCA Healthcare, Inc. $HCA
Foster & Motley Inc. has acquired a new stake of 28,296 shares in HCA Healthcare, Inc. (NYSE:HCA), valued at approximately $11.03 million during the second quarter. Other institutional investors have also adjusted their holdings in HCA, which recently reported strong quarterly earnings, beating analyst expectations with $7.59 EPS and $20.23 billion in revenue. The company also announced a quarterly dividend of $0.78 per share, and analysts currently have a "Moderate Buy" consensus rating with an average price target of $465.59.
Danske Bank A S Takes $116.86 Million Position in HCA Healthcare, Inc. $HCA
Danske Bank A S has acquired a new position in HCA Healthcare, Inc. (NYSE:HCA), purchasing 299,722 shares valued at approximately $116.86 million, representing 0.14% of the company. HCA Healthcare reported strong quarterly earnings, surpassing analyst expectations with $7.59 EPS and $20.23 billion in revenue, and has an average "Moderate Buy" rating from analysts with an average price target of $465.59. The company also declared a quarterly dividend of $0.78 per share, yielding 0.8%.
GSA Capital Partners LLP Takes Position in HCA Healthcare, Inc. $HCA
GSA Capital Partners LLP recently acquired 2,459 shares of HCA Healthcare, Inc. (NYSE:HCA), valued at approximately $959,000, bringing total institutional ownership to 62.73%. HCA Healthcare reported strong second-quarter earnings, exceeding analyst estimates with $7.59 EPS and $20.23 billion in revenue, an 8.7% year-over-year increase. The company also declared a quarterly dividend of $0.78 per share, and analysts maintain a "Moderate Buy" rating with an average price target of $465.59.
13,003,600 Shares in HCA Healthcare, Inc. $HCA Acquired by BlackRock Inc.
BlackRock Inc. has acquired a significant new stake in HCA Healthcare, purchasing 13,003,600 shares valued at approximately $5.07 billion, representing about 6.01% of the company. Other hedge funds have also adjusted their positions, and HCA Healthcare recently announced earnings that beat analyst estimates and a quarterly dividend of $0.78 per share. Analysts generally rate HCA Healthcare as a "Moderate Buy" with an average price target of $465.59.
Alamar Capital Management LLC Purchases New Holdings in HCA Healthcare, Inc. $HCA
Alamar Capital Management LLC has acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, purchasing 8,491 shares valued at approximately $3.31 million. This investment now represents 1.7% of Alamar Capital Management LLC's portfolio, making it their 9th largest holding. Other institutional investors have also adjusted their positions in HCA Healthcare, which has shown recent stock growth and strong quarterly earnings, topping analyst expectations.
RMTG Expands Cellgenic's Cancún Laboratory Infrastructure with Two Additional ISO 7 Clean Rooms
Regenerative Medical Technology Group, Inc. (RMTG) has expanded its Cellgenic division's laboratory in Cancún, Mexico, by adding two ISO 7 clean rooms. This investment aims to increase manufacturing capability, product development throughput, and quality systems capacity to support Cellgenic's growing international product portfolio, including NK cell, MUSE technologies, and peptide delivery. The expansion is a key part of RMTG's long-term international growth strategy and commitment to owned infrastructure, reducing supply and scaling risks.
HCA Healthcare Inc. stock outperforms competitors on strong trading day
HCA Healthcare Inc. (HCA) stock rose 1.67% to $411.73 on Tuesday, outperforming the broader market which saw the S&P 500 Index fall 0.69% and the Dow Jones Industrial Average fall 0.22%. This marks the stock's second consecutive day of gains.
Pzena Investment Management LLC Takes Position in HCA Healthcare, Inc. $HCA
Pzena Investment Management LLC recently acquired a new stake of 96,598 shares in HCA Healthcare, Inc. worth approximately $37.7 million. This move is part of broader institutional interest, with hedge funds and institutional investors owning 62.73% of the company. Despite some analysts lowering price targets, the consensus rating for HCA Healthcare remains a "Moderate Buy" with an average target price of $465.59, following a strong quarter where the company exceeded earnings and revenue expectations and declared a $0.78 quarterly dividend.
Citizens Financial Group Inc. RI Makes New Investment in HCA Healthcare, Inc. $HCA
Citizens Financial Group Inc. RI has significantly increased its stake in HCA Healthcare, Inc. (NYSE:HCA) by purchasing 65,367 shares valued at approximately $25.486 million in the second quarter. This new investment is part of a broader trend of institutional investors buying and selling shares in HCA Healthcare, which now has 62.73% institutional ownership. HCA Healthcare recently reported strong earnings, beating analyst expectations, and announced a quarterly dividend.
3,117 Shares in HCA Healthcare, Inc. $HCA Acquired by Global Retirement Partners LLC
Global Retirement Partners LLC acquired 3,117 shares of HCA Healthcare, Inc. (NYSE:HCA) valued at approximately $1.2 million during the second quarter. This move is part of a broader trend where institutional investors now own 62.73% of the company's stock, with several other major funds also increasing their positions. Despite some recent price target reductions, analysts maintain a "Moderate Buy" consensus rating for HCA Healthcare, with an average price target of $465.59.
HCA Healthcare 1Q Same-Facility Equivalent Admissions Up 1.3% >HCA
HCA Healthcare reported a 1.3% increase in same-facility equivalent admissions for the first quarter. This key metric indicates growth in patient volume across its existing facilities.
Does Surgery Partners’ (SGRY) Slower M&A Pace Clarify or Complicate Its ASC-Focused Strategy?
Surgery Partners (SGRY) recently reported Q2 2026 results with higher sales but wider net losses and a slower-than-planned M&A pace. The company is prioritizing portfolio optimization and divestitures to better align with its short-stay surgical focus, while still reaffirming its 2026 revenue guidance. This strategy emphasizes disciplined deal selection and tuck-in opportunities in a fragmented market, but investors should consider the potential impact of rising interest costs and slower deal flow on earnings.
Can Tenet Healthcare's Hospital Growth Keep Earnings Momentum Going?
Tenet Healthcare's (THC) Hospital Operations segment continues to drive strong earnings, with adjusted admissions increasing 2.6% year over year and revenue per adjusted admission rising 3.3% in Q2 2026. This growth is attributed to healthy patient demand, a better mix of services, and a focus on higher-acuity care, leading to a significant 22.3% jump in hospital adjusted EBITDA. Despite some pressure from weaker exchange enrollment, the company's cost-management efforts and a positive outlook for continued improvement position the segment as a strong tailwind for THC's earnings.
Oppenheimer Asset Management Inc. Makes New $1.43 Million Investment in HCA Healthcare, Inc. $HCA
Oppenheimer Asset Management Inc. has initiated a new position in HCA Healthcare, Inc. by purchasing 3,669 shares valued at approximately $1.43 million during the second quarter. HCA Healthcare reported strong quarterly results with revenue up 8.7% year-over-year to $20.23 billion and earnings exceeding analyst expectations. The company also declared a quarterly dividend of $0.78 per share, and analysts maintain a consensus "Moderate Buy" rating with an average price target of $465.59.
SCS Capital Management LLC Invests $7.21 Million in HCA Healthcare, Inc. $HCA
SCS Capital Management LLC has acquired a new stake of 18,480 shares in HCA Healthcare, Inc. (NYSE:HCA) valued at approximately $7.21 million during the second quarter. Other institutional investors have also adjusted their holdings in HCA, which recently reported strong earnings, beating consensus estimates, and announced a quarterly dividend of $0.78 per share. Analysts currently rate HCA Healthcare as a "Moderate Buy" with a consensus price target of $465.59.
Trivium Point Advisory LLC Takes $2.57 Million Position in HCA Healthcare, Inc. $HCA
Trivium Point Advisory LLC has acquired a new position in HCA Healthcare, Inc. (NYSE:HCA), purchasing 6,590 shares valued at approximately $2.57 million during the second quarter. This move is part of broader institutional investment, with other firms also adjusting their stakes in HCA, which reported strong quarterly earnings of $7.59 per share and $20.23 billion in revenue, surpassing analyst expectations. The company also declared a quarterly dividend of $0.78 per share, contributing to a "Moderate Buy" consensus among analysts.
Can Tenet Healthcare's Hospital Growth Keep Earnings Momentum Going?
Tenet Healthcare Corporation's Hospital Operations segment showed strong earnings growth in Q2 2026, with increased adjusted admissions and revenue per patient, leading to significant margin improvement. Despite some pressure from weaker exchange enrollment, the company's focus on high-acuity care, cost management, and strong commercial revenues are driving profitability. Peers like Universal Health Services and HCA Healthcare also reported solid hospital growth, indicating a healthy demand for hospital care.
Plato Investment Management Ltd Purchases Shares of 6,919 HCA Healthcare, Inc. $HCA
Plato Investment Management Ltd acquired 6,919 shares of HCA Healthcare, Inc. worth approximately $2.68 million during the second quarter. Other institutional investors also made significant moves in HCA Healthcare stock. HCA Healthcare reported strong Q2 earnings, beating analyst estimates, and announced a quarterly dividend of $0.78 per share.
HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring Growth Potential with a 12.33% Upside
HCA Healthcare (HCA) presents a compelling investment opportunity with a potential upside of 12.33%, based on an average analyst target price of $454.57. The company demonstrates strong financial health with robust revenue growth, impressive free cash flow, and positive analyst sentiment, including 14 buy ratings. Despite current price being below its 200-day moving average, technical indicators suggest bullish momentum for this significant player in the U.S. healthcare sector.
1ST Source Bank Invests $3.38 Million in HCA Healthcare, Inc. $HCA
1ST Source Bank has initiated a new position in HCA Healthcare, investing $3.38 million by purchasing 8,674 shares in the second quarter. The article notes that institutional investors and hedge funds collectively own 62.73% of HCA Healthcare's stock. Analysts generally maintain a "Moderate Buy" consensus rating for HCA, with an average price target of $465.59, following the company exceeding quarterly earnings expectations.
Sandro Wealth Management LLC Buys Shares of 6,627 HCA Healthcare, Inc. $HCA
Sandro Wealth Management LLC recently acquired 6,627 shares of HCA Healthcare, Inc. (NYSE:HCA) valued at approximately $2.584 million, making it about 1.9% of their portfolio. HCA Healthcare reported strong quarterly earnings with an EPS of $7.59 and revenue of $20.23 billion, exceeding analyst expectations, and declared a quarterly dividend of $0.78 per share. The company currently holds a "Moderate Buy" consensus rating from analysts with an average target price of $465.59.
HCA Healthcare Inc. stock underperforms Friday when compared to competitors
HCA Healthcare Inc. (HCA) stock fell by 1.71% on Friday, closing at $404.68, underperforming its competitors and the broader market. This decline occurred during a generally negative trading session, with the S&P 500 Index and Dow Jones Industrial Average also experiencing losses. This marks the second consecutive day of losses for HCA's stock.
HCA Healthcare (HCA) Stock May Be 49% Undervalued As Wage Pressure Builds
HCA Healthcare (HCA) stock appears significantly undervalued according to both Discounted Cash Flow (DCF) and P/E ratio analyses, despite a 75.1% return over the past five years. The valuation gap could be influenced by recent concerns over rising labor costs, staffing pressures, and leadership changes. Investors need to weigh whether the current share price already factors in these operational risks or if the valuation points to a margin of safety.
Surgery Partners (SGRY) Reaffirmed Guidance On Revenue Growth, Is It Still A Bargain?
Surgery Partners (SGRY) has garnered attention after reaffirming its full-year guidance and emphasizing a focus on higher acuity procedures, despite continued net losses. The company's stock is considered 15.4% undervalued, with a fair value estimated at $17.95, driven by the migration of high-acuity surgical procedures to outpatient settings and investments in robotics. However, the narrative faces risks from higher interest costs and slower-than-planned acquisitions.
HCA INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving HCA Healthcare, Inc.
Kirby McInerney LLP is investigating potential claims against HCA Healthcare, Inc. (NYSE:HCA) following a significant drop in its stock price. The investigation stems from HCA Healthcare's lowered 2026 profit guidance, which cited an unfavorable shift in payer mix and an increase in uninsured patients, impacting revenue by approximately $400 million. As a result, the company's stock fell by 6.95% on July 14, 2026.
Is Tenet Healthcare (THC) Overvalued Following Higher 2026 Adjusted EPS Guidance?
Tenet Healthcare (THC) has seen a significant surge in its share price and an increase in its 2026 adjusted EPS guidance, leading to questions about its valuation. While some analysts deem it overvalued at $250 compared to its last close of $267.05, others note its P/E ratio is lower than the industry average, suggesting potential mispricing or reflecting its high debt. The stock presents a mixed sentiment with strong momentum balanced against identified risks and rewards.
Rockwell Medical Q2 2026 slides: narrowing losses, targeting profitability
Rockwell Medical reported narrowing losses and increased revenue in Q2 2026, driven by new customers and operational efficiencies, despite narrowly missing analyst expectations. The company is progressing towards its goal of positive adjusted EBITDA for the full year 2026 and aims for significant growth and profitability by 2029 through strategic initiatives and portfolio diversification. Rockwell operates in a growing hemodialysis market, serving major providers and hospitals, and plans to expand its product offerings and global presence.
Could HCA Healthcare, Inc. (HCA) Stock Rebound After Guidance Cuts and Payer Pressure?
HCA Healthcare (HCA) recently reported Q2 2026 results with healthy revenue growth but revised full-year profitability guidance downward due to a policy-driven payer mix shift, leading to analyst price target cuts. While bears point to high debt and persistent margin drag from uninsured patients, bulls emphasize HCA's operating scale, strong cash flow, and strategy to expand outpatient services. Investors should monitor patient volume trends and labor expenses, although some AI stocks are suggested to offer better upside.
Assenagon Asset Management S.A. Lowers Stock Position in Tenet Healthcare Corporation $THC
Assenagon Asset Management S.A. significantly reduced its stake in Tenet Healthcare Corporation ($THC) by 60.7% in the second quarter, selling 74,968 shares but still retaining 48,533 shares valued at approximately $9.08 million. Despite this, institutional investors collectively own 95.44% of THC, and Wall Street analysts maintain a "Moderate Buy" consensus rating with an average price target of $272.25. The company recently reported strong quarterly earnings, beating analyst estimates, although insiders have sold a substantial amount of shares.
What Could HCA Healthcare (HCA) Union Protests Mean For Pay And Staffing?
HCA Healthcare is facing nationwide union protests demanding higher wages and improved staffing. These protests challenge HCA's core strategy of cost control and highlight tensions between the company's profits/share buybacks and frontline labor costs. The outcome of these negotiations will determine if HCA can maintain its margin profile or if it will need to recalibrate its model to absorb higher labor costs for potentially more stable growth.
